Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by stephenson1on May 18, 2018 6:17pm
199 Views
Post# 28055134

RE:LDS at 2nd Annual Canaccord Genuity Conference - Slides

RE:LDS at 2nd Annual Canaccord Genuity Conference - SlidesThanks for posting this - note from the 2018 earnings slide, a big jump is projected from July to August, from $4 million US to $8 million US.

And by end of the year, earnings from cannastrips and revuer are projected to be much smaller compared to their oil and extraction business.

Wish Brad had these slides prepared for that fateful BNN interview back on Jan 3 or 4, what a difference that would have made!

Simply LDS was not ready for that interview - and their business model keeps changing. No doubt it will change again from here as they go forward.

We will all be richly rewarded for hanging in there! JMO
Bullboard Posts